Pancrelipase Lipase

• Recruiting NCT NCT06099119

  Efficacy of PERT for PEI in Unresectable Pancreatic Cancer.

  Not yet reported Hospital Clinico Universitario de Santiago 100 participants Est. completion 2027-12 4 sites
  Other conditions: Unresectable Pancreatic Cancer
  View official trial listing →
• Recruiting NCT NCT06149546

  Exploring the Impact of a Multi-modal Nutritional Intervention in Patients Undergoing Chemotherapy for Pancreatic Cancer (FEED Trial)

  Not yet reported Cancer Trials Ireland 70 participants Est. completion 2028-11 1 site
  Other conditions: Pancreatic Cancer
  View official trial listing →
• Recruiting NCT NCT06477159

  Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency

  Not yet reported Ohio State University 30 participants Est. completion 2027-12-31 6 sites Stand-alone
  Other conditions: Exocrine Pancreatic Insufficiency
  View official trial listing →
• Recruiting NCT NCT06691893

  Evaluating the Efficacy of RELiZORB in Managing Exocrine Pancreatic Insufficiency in Tube-fed Pancreatitis Patients

  Not yet reported Massachusetts General Hospital 60 participants Est. completion 2027-07-15 1 site
  Other conditions: Exocrine Pancreatic Insufficiency (EPI), Pancreatitis
  View official trial listing →
• Recruiting NCT NCT06826105

  Pancrelipase With Nutritional Supplement in Patients at Risk of Malnutrition (EFFORT-ENZO)

  Not yet reported Philipp Schuetz 20 participants Est. completion 2027-01 1 site Stand-alone
  Other conditions: Malnutrition
  View official trial listing →
• Recruiting NCT NCT06883539

  A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.

  Not yet reported LaunXP Biomedical Co., Ltd. 24 participants Est. completion 2028-06-30 2 sites
  Other conditions: Solid Tumor Malignancies, Cancer, Solid Cancers, Solid Tumor Cancer, Solid Tumor, Unspecified, Adult, Solid Tumour, Solid Tumors Refractory to Standard Therapy, HCC - Hepatocellular Carcinoma, RCC, Renal Cell Cancer, Pancreas Cancer
  View official trial listing →
• Recruiting NCT NCT07074379

  Endotherapy and/or Extracorporeal Shockwave Lithotripsy for Painless Chronic Pancreatitis

  Not yet reported Changhai Hospital 126 participants Est. completion 2027-08-01 1 site
  Other conditions: Painless Chronic Pancreatitis
  View official trial listing →
• Recruiting NCT NCT07314489

  A Study on the Changes of Glucose Metabolism and Exocrine Function in Patients With Chronic Pancreatitis

  Not yet reported Shanghai Changzheng Hospital 80 participants Est. completion 2035-12-31 2 sites
  Other conditions: Chronic Pancreatitis Pancreatic Exocrine Insufficiency Blood Glucose
  View official trial listing →
• Recruiting NCT NCT07450547

  Phase 2 Study to Assess the Safety and Efficacy of ANG003

  Not yet reported Anagram Therapeutics, Inc. 113 participants Est. completion 2027-07 27 sites
  Other conditions: Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
  View official trial listing →
• Recruiting NCT NCT07591246

  Efficay of Physical Activity Program in PCOS Females With Fatty Pancrease and Thyroid Hypofunction

  Not yet reported Cairo University 40 participants Est. completion 2026-12-30 1 site
  Other conditions: Polycystic Ovary Syndrome, Non-Alcoholic Fatty Pancreatic Disease, Subclinical hypothyroïdism
  View official trial listing →
• Completed NCT NCT00006063

  Randomized Study of Pancrelipase With Bicarbonate (PANCRECARB) Capsules in Reducing Steatorrhea in Patients With Cystic Fibrosis

  Not yet reported National Center for Research Resources (NCRR) 24 participants Est. completion 1999-08
  Other conditions: Cystic Fibrosis
  View official trial listing →
• Completed NCT NCT00160186

  Gastrectomy Study: Study to Investigate the Effect of Creon 25000 Minimicrospheres on Body Mass Index (BMI) in Patients After Gastrectomy

  Not yet reported Solvay Pharmaceuticals 40 participants Est. completion 2006-05 9 sites
  Other conditions: Gastrectomy
  View official trial listing →
• Completed NCT NCT00217204

  An Effectiveness, Safety, and Palatability Study of Pancrelipase Microtablets in Infants and Toddlers With Cystic Fibrosis and Fat Malabsorption

  Not yet reported McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. 18 participants Est. completion 2006-02
  Other conditions: Cystic Fibrosis, Steatorrhea
  View official trial listing →
• Completed NCT NCT00266721

  Efficacy of Pancrelipase on Postprandial Belching and Bloating.

  Not yet reported Solvay Pharmaceuticals 45 participants Est. completion 2000-10 1 site
  Other conditions: Postprandial Bloating, Postprandial Belching, Postprandial Eructation
  View official trial listing →
• Completed NCT NCT00408317

  Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI)

  Not yet reported Forest Laboratories 36 participants Est. completion 2007-04 4 sites
  Other conditions: Cystic Fibrosis, Exocrine Pancreatic Insufficiency
  View official trial listing →
• Completed NCT NCT00414908

  A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy

  Not yet reported Solvay Pharmaceuticals 52 participants Est. completion 2009-12 30 sites Stand-alone
  Other conditions: Chronic Pancreatitis, Pancreatectomy, Pancreatic Exocrine Insufficiency
  View official trial listing →
• Completed NCT NCT00432861

  Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic Fibrosis

  Not yet reported Digestive Care, Inc. 29 participants Est. completion 2007-09 1 site
  Other conditions: Cystic Fibrosis, Pancreatic Insufficiency
  View official trial listing →
• Completed NCT NCT00510484

  Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

  Not yet reported Solvay Pharmaceuticals 35 participants Est. completion 2008-03 23 sites Stand-alone
  Other conditions: Cystic Fibrosis
  View official trial listing →
• Completed NCT NCT00510744

  Pancreatic Enzymes to Restore Digestive Function in Malnourished Gastric Bypass Patients

  Not yet reported University of Pittsburgh 5 participants Est. completion 2015-08 1 site
  Other conditions: Obesity
  View official trial listing →
• Completed NCT NCT00513682

  Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI)

  Not yet reported Forest Laboratories 9 participants Est. completion 2008-04 3 sites
  Other conditions: Cystic Fibrosis, Pancreatic Insufficiency
  View official trial listing →
• Completed NCT NCT00535756

  Creon After Pancreatic Surgery

  Not yet reported Abbott Products 58 participants Est. completion 2011-06 15 sites
  Other conditions: Pancreatic Insufficiency
  View official trial listing →
• Completed NCT NCT00559052

  An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE16 in Exocrine Pancreatic Insufficiency (EPI)

  Not yet reported Axcan Pharma 22 participants Est. completion 2009-02 2 sites
  Other conditions: Exocrine Pancreatic Insufficiency
  View official trial listing →
• Completed NCT NCT00559364

  Safety and Efficacy Study of Viokase® 16 for the Correction of Steatorrhea

  Not yet reported Forest Laboratories 50 participants Est. completion 2009-07 18 sites
  Other conditions: Exocrine Pancreatic Insufficiency, Chronic Pancreatitis, Pancreatectomy
  View official trial listing →
• Terminated NCT NCT00623025

  Creon in HIV Patients With Steatorrhea

  Not yet reported Abbott 34 participants Est. completion 2009-08 2 sites
  Other conditions: Steatorrhea
  View official trial listing →
• Completed NCT NCT00662675

  A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency

  Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 40 participants Est. completion 2009-02 11 sites
  Other conditions: Exocrine Pancreatic Insufficiency, Steatorrhea, Malabsorption Syndromes, Cystic Fibrosis
  View official trial listing →
• Withdrawn NCT NCT00663975

  Open Label Safety Study of DCI-1020 in Pediatric Cystic Fibrosis (CF) Patients

  Not yet reported Digestive Care, Inc. 24 participants Est. completion 2009-11 1 site Stand-alone
  Other conditions: Digestive System Diseases, Pancreatic Disease, Cystic Fibrosis, Exocrine Pancreatic Insufficiency
  View official trial listing →
• Completed NCT NCT00676702

  A Study of the Enzyme Activity and Safety of Pancrelipase in Patients With Severe Exocrine Pancreatic Insufficiency (EPI)

  Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 13 participants Est. completion 2009-01 Stand-alone
  Other conditions: Exocrine Pancreatic Insufficiency, Pancreatitis, Chronic, Steatorrhea, Pancreatitis
  View official trial listing →
• Completed NCT NCT00690820

  Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency (PEI) Due to Cystic Fibrosis (CF)

  Not yet reported Solvay Pharmaceuticals 17 participants Est. completion 2008-12 10 sites Stand-alone
  Other conditions: Cystic Fibrosis, Pancreatic Exocrine Insufficiency
  View official trial listing →
• Completed NCT NCT00705978

  Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic Pancreatitis

  Not yet reported Abbott Products 62 participants Est. completion 2010-05 11 sites
  Other conditions: Pancreatic Insufficiency
  View official trial listing →
• Terminated NCT NCT00744250

  Intraduodenal Aspiration Study to Assess the Bioavailability of Oral Pancrecarb® Compared to Placebo Control

  Not yet reported Digestive Care, Inc. 3 participants Est. completion 2010-05 1 site
  Other conditions: Exocrine Pancreatic Insufficiency, Chronic Pancreatitis, Cystic Fibrosis
  View official trial listing →
• Terminated NCT NCT00749099

  Bioavailability of Pancreatic Enzymes in the Human Upper Intestine (Duodenum and Jejunum)

  Not yet reported Digestive Care, Inc. 11 participants Est. completion 2010-09
  Other conditions: Exocrine Pancreatic Insufficiency
  View official trial listing →
• Completed NCT NCT00775528

  Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

  Not yet reported Solvay Pharmaceuticals 19 participants Est. completion 2009-06 12 sites Stand-alone
  Other conditions: Cystic Fibrosis, Pancreatic Exocrine Insufficiency
  View official trial listing →
• Completed NCT NCT00788593

  A Randomized, Double-Blind, Dose Response-Control, Crossover Study to Evaluate the Safety and Efficacy of Two Doses of EUR-1008 (APT-1008) in Chronic Pancreatitis (CP) Participants With Exocrine Pancreatic Insufficiency (EPI)

  Not yet reported Forest Laboratories 82 participants Est. completion 2009-03 18 sites
  Other conditions: Chronic Pancreatitis, Exocrine Pancreatic Insufficiency
  View official trial listing →
• Completed NCT NCT00880100

  Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF)

  Not yet reported Forest Laboratories 49 participants Est. completion 2009-11 15 sites
  Other conditions: Cystic Fibrosis, Pancreatic Insufficiency
  View official trial listing →
• Completed NCT NCT00957151

  Evaluation of the Digestive and Metabolic Utilisation of Dietary Protein in Patients With Chronic Pancreatitis

  Not yet reported Hospital Avicenne 12 participants Est. completion 2005-08
  Other conditions: Chronic Pancreatitis
  View official trial listing →
• Completed NCT NCT00981214

  Study of Pancreatic Enzyme Product in Pediatric Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency

  Not yet reported Forest Laboratories 19 participants Est. completion 2006-09 14 sites
  Other conditions: Cystic Fibrosis, Exocrine Pancreatic Insufficiency
  View official trial listing →
• Status unknown NCT NCT01012908

  Clinical Non-Inferiority of Pancreatic Enzymes (Norzyme ® - Bergamo) Compared To Creon ® (Solvay Pharmaceutical) in Patients With Exocrine Pancreatic Insufficiency

  Not yet reported, Not yet reported Azidus Brasil 25 participants Est. completion 2011-06 1 site
  Other conditions: Pancreatic Insufficiency
  View official trial listing →
• Completed NCT NCT01100606

  A Study to Evaluate the Mode of Administration and Safety of EUR-1008 (APT-1008) in Infants 1 to 12 Months of Age

  Not yet reported Forest Laboratories 15 participants Est. completion 2010-12 6 sites Stand-alone
  Other conditions: Cystic Fibrosis, Exocrine Pancreatic Insufficiency
  View official trial listing →
• Withdrawn NCT NCT01114113

  Assessment of Gastric Emptying Speed in Patients Who Experience Diarrhea Following a Trigger Meal

  Not yet reported Money, Mary E., M.D. Est. completion 2011-01
  Other conditions: Irritable Bowel Syndrome, Diarrhea
  View official trial listing →
• Completed NCT NCT01131507

  PR-018: An Open-Label, Safety Extension of Study PR-011

  Not yet reported Forest Laboratories 15 participants Est. completion 2011-12 6 sites Stand-alone
  Other conditions: Cystic Fibrosis, Exocrine Pancreatic Insufficiency
  View official trial listing →
• Terminated NCT NCT01142128

  Viokase 16, Viokase16 Plus Nexium and Nexium Alone

  Not yet reported University of Florida 12 participants Est. completion 2012-03 1 site
  Other conditions: Chronic Pancreatitis
  View official trial listing →
• Completed NCT NCT01154608

  Effect of Enzyme Therapy on Protein Metabolism in Chronic Pancreatitis

  Not yet reported Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement 11 participants 1 site
  Other conditions: Pancreatitis
  View official trial listing →
• Terminated NCT NCT01159119

  A Study of EUR-1066 in Subjects With Chronic Pancreatitis, Exocrine Pancreatic Insufficiency and Chronic Abdominal Pain

  Not yet reported Forest Laboratories 15 participants Est. completion 2011-07-01 1 site
  Other conditions: Chronic Pancreatitis
  View official trial listing →
• Withdrawn NCT NCT01228643

  Effectiveness of Pancreatic Enzymes in Patients Pancreatic Insufficient: Comparison of Two Drugs

  Not yet reported Azidus Brasil Est. completion 2011-12 1 site
  Other conditions: Chronic Renal Failure
  View official trial listing →
• Completed NCT NCT01327703

  Control of Steatorrhea in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency

  Not yet reported Forest Laboratories 87 participants Est. completion 2012-05 13 sites
  Other conditions: Exocrine Pancreatic Insufficiency, Cystic Fibrosis
  View official trial listing →
• Withdrawn NCT NCT01401387

  Pancreatic Enzyme Suppletion in Pancreatic Cancer

  Not yet reported Foundation for Liver Research Est. completion 2013-05 1 site
  Other conditions: Adenocarcinoma of the Pancreas, Normal Pancreatic Exocrine Function
  View official trial listing →
• Completed NCT NCT01427712

  Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

  Mylan Inc. 24 participants Est. completion 2018-03 21 sites
  Other conditions: Cystic Fibrosis, Exocrine Pancreatic Insufficiency, Pancreatic Diseases, Digestive System Diseases
  View official trial listing →
• Completed NCT NCT01427725

  Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency

  Mylan Inc. 579 participants Est. completion 2015-04 189 sites
  Other conditions: Exocrine Pancreatic Insufficiency, Pancreatic Diseases, Digestive System Diseases
  View official trial listing →
• Completed NCT NCT01430234

  Enzyme Suppletion in Exocrine Pancreatic Dysfunction

  Not yet reported Foundation for Liver Research 10 participants Est. completion 2013-02 1 site
  Other conditions: Chronic Pancreatitis, Exocrine Pancreatic Insufficiency
  View official trial listing →
• Completed NCT NCT01641341

  Irritable Bowel Syndrome Evaluation and Treatment in Primary Care

  Not yet reported American Academy of Family Physicians 61 participants Est. completion 2012-03 9 sites
  Other conditions: Irritable Bowel Syndrome
  View official trial listing →
• Completed NCT NCT01641393

  Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

  Not yet reported Forest Laboratories 96 participants Est. completion 2014-02 37 sites
  Other conditions: Exocrine Pancreatic Insufficiency: Cystic Fibrosis
  View official trial listing →
• Terminated NCT NCT01652157

  Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

  AbbVie 17 participants Est. completion 2020-04-08 123 sites
  Other conditions: Fibrosing Colonopathy
  View official trial listing →
• Completed NCT NCT01663272

  A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic Cancer

  Not yet reported University of Michigan Rogel Cancer Center 12 participants Est. completion 2017-03-01 1 site
  Other conditions: Pancreatic Cancer
  View official trial listing →
• Status unknown NCT NCT01717807

  C11-Erlotinib PET/CT as a Tool for Identification and Characterization of Tumor With High Expression of Epidermal Growth Factor Receptor(EGFR).

  Hadassah Medical Organization 30 participants 1 site
  Other conditions: Lung Cancer, Pancreatic Cancer
  View official trial listing →
• Completed NCT NCT01747330

  Evaluation of Safety and Tolerability of Creon Micro in Children Younger Than Four Years With Pancreatic Exocrine Insufficiency

  Not yet reported Abbott Products 40 participants Est. completion 2012-12 9 sites
  Other conditions: Pancreatic Exocrine Insufficiency
  View official trial listing →
• Status unknown NCT NCT01771146

  Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease Cancer

  Not yet reported Baylor Research Institute 30 participants Est. completion 2020-09 1 site
  Other conditions: Pancreas Cancer, Localized Pancreas Cancer, Non-metastatic Pancreas Cancer
  View official trial listing →
• Terminated NCT NCT01865695

  Creon Use in Coeliac Patients With Low Faecal Pancreatic Elastase

  Not yet reported Sheffield Teaching Hospitals NHS Foundation Trust 2 participants Est. completion 2014-08 1 site
  Other conditions: Patients With Coeliac Disease and Chronic Diarrhoea (>3 Loose/ Liquid Motions a Day for More Than 4 Weeks), Patients With Pancreatic Exocrine Insufficiency
  View official trial listing →
• Withdrawn NCT NCT02009410

  A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in Subjects With Diabetes Mellitus Type 2

  Not yet reported Abbott Est. completion 2014-08 10 sites
  Type 2 diabetes
  View official trial listing →
• Status unknown NCT NCT02097394

  The Clinical Study on Combizym and Bifidobacteri to Prevent the Recurrence of Colon Polyps

  Not yet reported RenJi Hospital 200 participants Est. completion 2020-06 1 site
  Other conditions: Combizym, Bifidobacteri, Colon Polyps
  View official trial listing →
• Completed NCT NCT02137382

  A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect of Creon N and Creon® on Fat Digestion in Subjects ≥ 12 Years of Age With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

  Not yet reported Abbott 41 participants Est. completion 2014-08 7 sites
  Other conditions: Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis
  View official trial listing →
• Completed NCT NCT02372383

  Improving Treatment of Nontuberculous Mycobacterial Infection in Cystic Fibrosis

  Not yet reported University of Colorado, Denver 31 participants Est. completion 2016-06 1 site Stand-alone
  Other conditions: Cystic Fibrosis
  View official trial listing →
• Status unknown NCT NCT02372526

  The Effect of Different Macronutrients on Gastrointestinal Hormone Secretion After Gastric Bypass Operation

  Kirstine Nyvold Bojsen-Moeller 18 participants Est. completion 2017-06 1 site
  Other conditions: Bariatric Surgery (Gastric Bypass), Overweight
  View official trial listing →
• Completed NCT NCT02415959

  Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

  Not yet reported Abbott 70 participants Est. completion 2015-07 17 sites
  Other conditions: Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis
  View official trial listing →
• Terminated NCT NCT02475369

  Pancreatic Enzyme Supplementation for Celiac Disease

  Not yet reported Beth Israel Deaconess Medical Center 21 participants Est. completion 2019-12 1 site
  Other conditions: Celiac Disease
  View official trial listing →
• Withdrawn NCT NCT02706236

  Trial of Pancreatic Enzyme Supplements (Pancrelipase) for Treating Pain in Patients With Chronic Pancreatitis

  Not yet reported Dartmouth-Hitchcock Medical Center Est. completion 2018-12 1 site
  Other conditions: Pancreatitis
  View official trial listing →
• Terminated NCT NCT02733848

  CREON for the Treatment of Post-RYGB Hypoglycemia

  Not yet reported East Carolina University 5 participants Est. completion 2018-01-31
  Other conditions: Hypoglycemia
  View official trial listing →
• Completed NCT NCT02767531

  Orlistat for the Treatment of Type I Hyperlipoproteinemia

  Not yet reported University of Texas Southwestern Medical Center 2 participants Est. completion 2022-12-31 1 site
  Other conditions: Hyperlipoproteinemia Type I, Hypertriglyceridemia
  View official trial listing →
• Completed NCT NCT02849704

  Fat Malabsorption in Chronic Pancreatitis

  Not yet reported Children's Hospital of Philadelphia 48 participants Est. completion 2017-11-01 1 site
  Other conditions: Chronic Pancreatitis
  View official trial listing →
• Terminated NCT NCT02985801

  PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer

  Not yet reported, Not yet reported Massimo Raimondo, M.D. 16 participants Est. completion 2019-04 1 site Stand-alone
  Other conditions: Pancreatic Insufficiency, Pancreatic Cancer, Pancreatic Enzyme Abnormality
  View official trial listing →
• Completed NCT NCT03097029

  Use of Pancreatic Enzymes in Short Bowel Syndrome

  Not yet reported Children's Hospital of Philadelphia 16 participants Est. completion 2019-02-01 1 site
  Other conditions: Short Bowel Syndrome
  View official trial listing →
• Completed NCT NCT03350958

  Bioactive Dietary Fibres and Obesity

  Not yet reported Newcastle-upon-Tyne Hospitals NHS Trust 29 participants Est. completion 2013-03-07
  Other conditions: Obesity
  View official trial listing →
• Status unknown NCT NCT03450772

  Equivalence Study to Compare Two Strengths of Creon in China

  Not yet reported Abbott 60 participants Est. completion 2022-04-30 1 site
  Other conditions: Pancreatic Insufficiency
  View official trial listing →
• Terminated NCT NCT03469258

  Study of Pancreatic Enzyme Replacement on Completion of Adjuvant Chemotherapy for Resected Pancreatic Adenocarcinoma

  Not yet reported Dana-Farber Cancer Institute 4 participants Est. completion 2019-10-01 1 site Stand-alone
  Other conditions: Pancreatic Cancer
  View official trial listing →
• Completed NCT NCT03616431

  Pancreatic Cancer Dietary Assessment Study

  The Christie NHS Foundation Trust 112 participants Est. completion 2021-05-31 1 site
  Other conditions: Pancreatic Neoplasm, Pancreas Adenocarcinoma, Well-Differentiated Neuroendocrine Carcinoma, Malignant Neoplasm of Pancreas
  View official trial listing →
• Completed NCT NCT03746483

  OPTION: A Trial to Assess the Safety & Efficacy of MS1819 in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

  Not yet reported Entero Therapeutics 41 participants Est. completion 2019-07-27 14 sites
  Other conditions: Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
  View official trial listing →
• Terminated NCT NCT03757455

  ERAS Protocol in Pancreaticoduodenectomy and Total Pancreatectomy

  Not yet reported Tampere University Hospital 35 participants Est. completion 2021-10-01 1 site
  Other conditions: Pancreatic Cancer, Surgery--Complications, Pancreatic Fistula, Delayed Gastric Emptying, Pancreatic Hemorrhage
  View official trial listing →
• Terminated NCT NCT03859869

  A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI)

  Not yet reported AbbVie 1 participants Est. completion 2022-03-23 33 sites Stand-alone
  Other conditions: Exocrine Pancreatic Insufficiency (EPI)
  View official trial listing →
• Completed NCT NCT03924947

  A Study to Compare US Marketed Creon Manufactured With a Modernized Process at an Alternate Manufacturing Site and Manufactured With the Approved Manufacturing Process at an Alternate Active Pharmaceutical Ingredient Site, in Participants With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

  Not yet reported AbbVie 36 participants Est. completion 2022-07-11 13 sites Stand-alone
  Other conditions: Cystic Fibrosis
  View official trial listing →
• Status unknown NCT NCT04057326

  A Study of Oryz-Aspergillus Enzyme and Pancreatin Tablet in Patients With Cirrhosis and Malnutrition

  Not yet reported Shenzhen Kangzhe Pharmaceutical Co., Ltd. 132 participants Est. completion 2021-03-28
  Other conditions: Cirrhosis
  View official trial listing →
• Status unknown NCT NCT04079777

  Relationship Between Acute Severe Pancreatitis and Mitochondrial DNA

  First People's Hospital of Chenzhou 50 participants Est. completion 2020-06 1 site
  Other conditions: Severe Acute Pancreatitis
  View official trial listing →
• Active, not recruiting NCT NCT04098237

  Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic Insufficiency

  Not yet reported Andrew Hendifar, MD 36 participants Est. completion 2027-01 1 site Stand-alone
  Other conditions: Pancreatic Adenocarcinoma
  View official trial listing →
• Withdrawn NCT NCT04315311

  Study Of Effects Of Oral CREON Capsules In Adult Participants With Exocrine Pancreatic Insufficiency Not Due To Cystic Fibrosis, Chronic Pancreatitis, Pancreatectomy, Or Pancreatic Cancer

  Not yet reported AbbVie Est. completion 2021-09-22
  Other conditions: Exocrine Pancreatic Insufficiency (EPI)
  View official trial listing →
• Completed NCT NCT04375878

  OPTION 2: A Trial to Assess the Safety and Efficacy of MS1819 in Enteric Capsules in Patients With Cystic Fibrosis

  Not yet reported Entero Therapeutics 27 participants Est. completion 2021-04-08 15 sites
  Other conditions: Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
  View official trial listing →
• Status unknown NCT NCT04542473

  Pancreatic Enzymes and Bile Acids in Acutely Ill Severely Malnourished Children

  Not yet reported, Not yet reported University of Oxford 400 participants Est. completion 2024-06-30 4 sites
  Other conditions: SEPSIS, MALNUTRITION, CHILD
  View official trial listing →
• Status unknown NCT NCT04786795

  MITE in the Treatment of Dyspepsia After Cholecystectomy

  Not yet reported Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 990 participants Est. completion 2022-02
  Other conditions: Patients With Dyspeptic Symptoms After Cholecystectomy
  View official trial listing →
• Completed NCT NCT04949828

  Effect of CREON on Exocrine Pancreatic Insufficiency (EPI) Symptoms

  AbbVie 63 participants Est. completion 2024-02-29 6 sites
  Other conditions: Chronic Pancreatitis
  View official trial listing →
• Completed NCT NCT05069597

  Study to Evaluate Symptoms of Exocrine Pancreatic Insufficiency in Adult Participants With Cystic Fibrosis or Chronic Pancreatitis Treated With Creon

  Not yet reported AbbVie 30 participants Est. completion 2023-08-28 21 sites
  Other conditions: Cystic Fibrosis, Chronic Pancreatitis
  View official trial listing →
• Status unknown NCT NCT05261997

  Endotherapy for Painless Chronic Pancreatitis

  Not yet reported Changhai Hospital 60 participants Est. completion 2023-11 1 site
  Other conditions: Pancreatitis, Chronic, Exocrine Pancreatic Insufficiency, Abdominal Pain, Cholangiopancreatography, Endoscopic Retrograde
  View official trial listing →
• Status unknown NCT NCT05265663

  Stereotactic Radiotherapy vs Best Supportive Care in Unfit Pancreatic Cancer Patients

  Not yet reported Amsterdam UMC, location VUmc 98 participants Est. completion 2024-06-01 2 sites
  Other conditions: Pancreatic Cancer Non-resectable
  View official trial listing →
• Completed NCT NCT05266963

  Pancreatic Enzyme Replacement and Glucose Regulation in Type 1 Diabetes

  Not yet reported Vanderbilt University Medical Center 11 participants Est. completion 2024-03-22 1 site
  Other conditions: Type 1 Diabetes
  View official trial listing →
• Completed NCT NCT05601258

  Lipase Levels and Coronavirus Disease 2019

  Uşak University 4000 participants Est. completion 2021-07-09 1 site
  Other conditions: Pancreatitis, Lipase Increased
  View official trial listing →
• Active, not recruiting NCT NCT05642962

  Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)

  Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 17 participants Est. completion 2026-11-30 7 sites Stand-alone
  Other conditions: Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma, Metastatic Pancreatic Carcinoma, Pancreatic Carcinoma, Pancreatic Carcinoma Metastatic, Pancreatic Carcinoma Non-resectable, Pancreatic Cancer, Pancreatic Cancer Non-resectable, Pancreatic Cancer Stage IV, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma
  View official trial listing →
• Status unknown NCT NCT06119880

  The Effect of PERT on Patients Undergoing Pancreaticoduodenectomy

  Not yet reported Ruijin Hospital 100 participants Est. completion 2025-12-31 1 site
  Other conditions: Pancreatic Exocrine Insufficiency, Pancreatic Enzyme Replacement Therapy, Pancreaticoduodenectomy
  View official trial listing →
• Status unknown NCT NCT06320379

  Zypan Functional Dyspepsia

  Not yet reported National University of Natural Medicine 64 participants Est. completion 2024-12-31 1 site
  Other conditions: Dyspepsia
  View official trial listing →
• Enrolling by invitation NCT NCT06512818

  Effect of Psiguavin for Obesity Treatment (PSIGUAVIN)

  Not yet reported, Not yet reported Universidad Católica San Antonio de Murcia 100 participants Est. completion 2027-12-19 1 site
  Other conditions: Obesity, Overweight or Obesity
  View official trial listing →
• Not yet recruiting NCT NCT07557394

  A Prospective Non-randomized Controlled Interventional Study on the Effect of Shouhui Tongbian Capsules Combined With Pancreatin Enteric-coated Capsules on Pancreatic Exocrine Function in Patients After Curative Resection for Pancreatic Cancer

  Not yet reported Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 80 participants Est. completion 2028-04-30
  Other conditions: Pancreatic Cancer
  View official trial listing →
• Not yet recruiting NCT NCT07559175

  A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.

  Not yet reported Aimmune Nestlé Health Science US R&D, LLC 66 participants Est. completion 2027-09 30 sites
  Other conditions: Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF), Pancreatic Enzyme Abnormality, Pancreatic Diseases
  View official trial listing →
• Not yet recruiting NCT NCT07751367

  A Study on the Efficacy of Different Doses of Oryz-Aspergillus Enzyme And Pancreatin Tablet in Treating Pancreatic Exocrine Insufficiency After Gastrointestinal Surgery

  Not yet reported Tianjin Medical University Cancer Institute and Hospital 150 participants Est. completion 2028-12-31 1 site
  Other conditions: Pancreatic Exocrine Insufficiency, Adul
  View official trial listing →

Not yet reported.

Not yet reported.

• ClinicalTrials.gov — NCT06826105

Also known as: Pancrelipase Lipase, Zenpep, Pancrelipase

No related coverage yet.